ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 6,647 | 10,899 | 10,532 | 7,836 | 6,152 |
| Cost of Goods | 2,117 | 2,622 | 2,685 | 2,710 | 2,171 |
| Gross Profit | 4,530 | 8,277 | 7,847 | 5,126 | 3,981 |
| Operating Expenses | 7,107 | 5,404 | 5,072 | 5,026 | 7,927 |
| Operating Income | -2,460 | 3,495 | 3,460 | 810 | -3,775 |
| Interest Expense | -3 | 0 | 0 | 0 | 374 |
| Other Income | -39 | 29 | 31 | 148 | -434 |
| Pre-tax Income | -2,496 | 3,524 | 3,491 | 958 | -4,583 |
| Income Tax | -133 | 165 | 103 | -83 | N/A |
| Net Income Continuous | -2,363 | 3,359 | 3,388 | 1,041 | -4,583 |
| Net Income Discontinuous | N/A | N/A | 45 | 150 | N/A |
| Net Income | $-2,363 | $3,359 | $3,433 | $1,191 | $-4,583 |
| EPS Basic Total Ops | -0.21 | 0.33 | 4.98 | 0.13 | -6.03 |
| EPS Basic Continuous Ops | -0.21 | 0.34 | 2.90 | 0.11 | -3.97 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.02 | 0.02 | N/A |
| EPS Diluted Total Ops | -0.21 | 0.33 | 4.98 | 0.13 | -6.03 |
| EPS Diluted Continuous Ops | -0.21 | 0.34 | 2.90 | 0.11 | -3.97 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.02 | 0.02 | N/A |
| EBITDA(a) | $-1,754 | $4,198 | $3,897 | $1,192 | $-3,629 |